Sareum - Specialists in Cancer Drug Discovery
Print the page Smaller text Larger text

 

Holdings in Company
02 September, 2010

Total Voting Rights
31 August, 2010

Issue of Equity
03 August, 2010

NOMAD Change of Name
12 July, 2010

Sareum to Present at EPIC 2010
23 June, 2010

RSS news feed News feed
requires RSS news reader

Sareum Holdings
Last Trading 0.29
Trade Time 15:27am
Change -0.05
Open 0.34
Day's Range 0.29 - 0.33
Volume 1700834

 

Sareum's small molecule drug discovery expertise is building value by developing oncology drug candidates for licencing to pharmaceutical and biotechnology companies

Providing protein structure-based research services to accelerate customers’ drug discovery programmes
Developing oncology drug candidates for licensing to pharmaceutical companies
Learn more about Sareum’s pre-clinical oncology pipeline of targeted small molecule drug candidates
Sareum Holdings Plc's house broker, Hybridan LLP, will from time to time publish research notes on the Company. You can download the research notes from this page.
 
2009 Annual Report & Accounts is available for download here:
  Annual Report 2009 
 
Website last updated on: 26-April-2010
 


Requires RSS news reader

Requires MS Word

Requires Adobe Acrobat Reader


site map

email: info@sareum.co.uk tel: +44 (0) 1223 497700 fax: +44 (0) 1223 497701